Background: Numbers of patients with stage 5 chronic kidney disease (CKD) managed
conservatively (without dialysis) are increasing steadily but prevalence and severity of symptoms …

CONTEXT: Palliative care is being advocated for noncancer patients but needs evidence of
effectiveness and cost-effectiveness. OBJECTIVE: We evaluated the cost-effectiveness of a …

The numbers of patients dying with end-stage renal disease (ESRD), particularly those
managed conservatively (without dialysis) or withdrawing from dialysis is increasing rapidly in …

Objectives Multiple myeloma ( MM ) is an incurable haematological disease. Due to novel
agents, overall survival has improved in this group, yet there are no systematic reviews to …

Background Multiple myeloma, the second most common haematological cancer, remains
incurable. Its incidence is rising due to population ageing. Despite the impact of the disease …

Background Multiple myeloma is an incurable haematological cancer that affects physical,
psychological and social domains of quality of life (QOL). Treatment decisions are …

Objectives: To explore patients’ understanding of their symptoms and the treatment of their
heart failure. Design: Qualitative analysis of in‐depth interviews, using a constant …

Introduction Treatment advances in multiple myeloma have increased expected survival from
months to years for some patients. Alongside improved survival emerges a need to better …

The support team assessment schedule (STAS) has previously been validated as an evaluation
tool for community palliative care teams and inpatient units. This study reports on use of …

Background Multiple myeloma is an incurable cancer with a rising incidence globally. Less
toxic treatments are increasingly available, so patients are living longer and treatment …